Exforge gets U.S. approval, Novartis says

Published: 2007-01-17 07:00:00
Updated: 2007-01-17 07:00:00
Swiss drugmaker Novartis AG said its Exforge antihypertensive medication has recently received approval from the U.S. Food and Drug Administration (FDA).

Exforge combines valsartan and amlodipine besylate in one pill.

"Exforge is expected to be available to patients in the U.S. in late Sep...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.